journal article·2022-10-09Open access

Platelet Membrane–Encapsulated MSNs Loaded with SS31 Peptide Alleviate Myocardial Ischemia-Reperfusion Injury

Zaiyuan Zhang, Zhong Chen, Ling Yang, Jian Zhang, Yubo Li, Chengming Li, Rui Wang, Xue Wang, Shuo Huang, Yonghe Hu, Jianyou Shi, Wenjing Xiao

Abstract

Clinically, antioxidant therapy is a potential strategy for myocardial ischemia-reperfusion injury (MI/RI), a common complication of acute myocardial ischemia. The H-D-Arg-Dmt-Ly-Phe-NH2 (SS31) peptide is shown to have amazing antioxidant properties, but its utilization is limited by the peptide characteristics, such as the destruction by proteases and rapid metabolism. Silica nanoparticles (MSNs) comprise an excellent material for peptide delivery, owing to the protection effect relating to peptides. Moreover, platelet membrane (PLTM) is shown to be advantageous as a coat for nanosystems because of its specific protein composition, such that a PLTM-coated nanosystem has a stealth effect in vivo, able to target injury in the cardiovascular system. Based on this feature, we designed and prepared a novel nanocarrier to target SS31 delivery. This carrier is encapsulated by a platelet membrane and loaded with SS31 peptide into MSNs. The results reveal that this delivery system can target SS31 to the injured cardiovascular site, exert antioxidant function, and alleviate MI/RI.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Fuel Cells and Related Materials · Cardiac Ischemia and Reperfusion · Electrospun Nanofibers in Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Medicine, Southwest Jiaotong University, Chengdu 610031, China

Department of Ultrasound, The General Hospital of Western Theater Command of PLA, Chengdu 610083, China

School of Clinical Medicine, Chengdu University of TCM, Chengdu 610072, China

College of Integrated Traditional Chinese and Western Medicine, Southwest Medical University, Luzhou 646000, China

Personalized Drug Therapy Key Laboratory of Sichuan Province, Department of Pharmacy, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China

Department of Pharmacy, The General Hospital of Western Theater Command of PLA, Chengdu 610083, China

School of Materials Science and Engineering, Southwest Jiaotong University, Chengdu 611756, China

Funding

Sichuan Provincial Health Commission · National Natural Science Foundation of China · Science & Technology Department of Sichuan Province · Key Research and Develop-ment Program of Science and Technology Department of Sichuan Province · Clinical Research and Transformation Fund of Sichuan Provincial People’s Hospital · Individual drug therapy small molecule innovative medicine Sichuan Youth Science and Technology Innovation Research team

References (55)

Show source-provided references
1. Effect of aqueous extract of sanweitanxiang powder on calcium homeostasis protein expression in ischemic-reperfusion injury rat heart10.1016/S0254-6272(13)60178-8 ↗
2. Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury: JACC Review Topic of the Week10.1016/j.jacc.2018.09.086 ↗
3. Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy10.1016/j.amjcard.2010.03.032 ↗
4. ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotection10.1016/j.freeradbiomed.2018.01.024 ↗
5. Platelets as drivers of ischemia/reperfusion injury after stroke10.1182/bloodadvances.2020002888 ↗
6. The Role of Oxidative Stress in Myocardial Ischemia and Reperfusion Injury and Remodeling: Revisited10.1155/2016/1656450 ↗
7. Inhibition of mitochondrial permeability transition pore opening: The Holy Grail of cardioprotection10.1007/s00395-009-0080-9 ↗
8. A highly potent peptide analgesic that protects against ischemia-reperfusion-induced myocardial stunning10.1152/ajpheart.00193.2002 ↗
9. Mitochondria-Targeted Peptide Accelerates ATP Recovery and Reduces Ischemic Kidney Injury10.1681/ASN.2010080808 ↗
10. ROS-responsive chitosan-SS31 prodrug for AKI therapy via rapid distribution in the kidney and long-term retention in the renal tubule10.1126/sciadv.abb7422 ↗
11. In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles10.1002/adma.201205292 ↗
12. New advances in gated materials of mesoporous silica for drug controlled release10.1016/j.cclet.2021.06.034 ↗
13. Narayan, R., Nayak, U.Y., Raichur, A.M., and Garg, S. (2018). Mesoporous Silica Nanoparticles: A Comprehensive Review on Synthesis and Recent Advances. Pharmaceutics, 10.10.3390/pharmaceutics10030118 ↗
14. Porous Silicon and Polymer Nanocomposites for Delivery of Peptide Nucleic Acids as Anti-MicroRNA Therapies10.1002/adma.201601646 ↗
15. MSN-mediated sequential vascular-to-cell nuclear-targeted drug delivery for efficient tumor regression10.1002/adma.201402752 ↗
16. Preparation of mesoporous silica nanoparticle with tunable pore diameters for encapsulating and slowly releasing eugenol10.1016/j.cclet.2020.12.033 ↗
17. Nanoparticle biointerfacing by platelet membrane cloaking10.1038/nature15373 ↗
18. Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium10.1016/j.cardiores.2003.11.036 ↗
19. Platelet-Inspired Nanocells for Targeted Heart Repair After Ischemia/Reperfusion Injury10.1002/adfm.201803567 ↗
20. Drug Targeting via Platelet Membrane-Coated Nanoparticles10.1002/sstr.202000018 ↗
21. Ultrasound Controlled Anti-Inflammatory Polarization of Platelet Decorated Microglia for Targeted Ischemic Stroke Therapy10.1002/anie.202010391 ↗
22. Platelet Membrane Biomimetic Magnetic Nanocarriers for Targeted Delivery and in Situ Generation of Nitric Oxide in Early Ischemic Stroke10.1021/acsnano.9b08587 ↗
23. GQDs-MSNs nanocomposite nanoparticles for simultaneous intracellular drug delivery and fluorescent imaging10.1007/s11051-018-4416-y ↗
24. Mitochondria-targeted cyclosporin A delivery system to treat myocardial ischemia reperfusion injury of rats10.1186/s12951-019-0451-9 ↗
25. Engineered Cell-Penetrating Peptides for Mitochondrion-Targeted Drug Delivery in Cancer Therapy10.1002/chem.202102523 ↗
26. Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-mediated mtDNA maintenance10.7150/thno.50905 ↗
27. Chen, D., Jin, Z., Zhang, J., Jiang, L., Chen, K., He, X., Song, Y., Ke, J., and Wang, Y. (2016). HO-1 Protects against Hypoxia/Reoxygenation-Induced Mitochondrial Dysfunction in H9c2 Cardiomyocytes. PLoS ONE, 11.10.1371/journal.pone.0153587 ↗
28. Quercetin regulates inflammation, oxidative stress, apoptosis, and mitochondrial structure and function in H9C2 cells by promoting PVT1 expression10.1016/j.acthis.2021.151819 ↗
29. Suppression of Stim1 reduced intracellular calcium concentration and attenuated hypoxia/reoxygenation induced apoptosis in H9C2 cells10.1042/BSR20171249 ↗
30. Hydrogen gas inhalation alleviates myocardial ischemia-reperfusion injury by the inhibition of oxidative stress and NLRP3-mediated pyroptosis in rats10.1016/j.lfs.2021.119248 ↗
31. AM1241 alleviates myocardial ischemia-reperfusion injury in rats by enhancing Pink1/Parkin-mediated autophagy10.1016/j.lfs.2021.119228 ↗
32. Substance-P Prevents Cardiac Ischemia-Reperfusion Injury by Modulating Stem Cell Mobilization and Causing Early Suppression of Injury-Mediated Inflammation10.33594/000000004 ↗
33. Yuan, Y., Zhai, Y., Chen, J., Xu, X., and Wang, H. (2021). Kaempferol Ameliorates Oxygen-Glucose Deprivation/Reoxygenation-Induced Neuronal Ferroptosis by Activating Nrf2/SLC7A11/GPX4 Axis. Biomolecules, 11.10.3390/biom11070923 ↗
34. Cardioprotection of CAPE-oNO2 against myocardial ischemia/reperfusion induced ROS generation via regulating the SIRT1/eNOS/NF-kappaB pathway in vivo and in vitro10.1016/j.redox.2017.11.023 ↗
35. Sequentially Site-Specific Delivery of Thrombolytics and Neuroprotectant for Enhanced Treatment of Ischemic Stroke10.1021/acsnano.9b01798 ↗
36. Platelet-membrane-biomimetic nanoparticles for targeted antitumor drug delivery10.1186/s12951-019-0494-y ↗
37. Xie, Q., Zeng, J., Zheng, Y., Li, T., Ren, J., Chen, K., Zhang, Q., Xie, R., Xu, F., and Zhu, J. (2021). Mitochondrial Transplantation Attenuates Cerebral Ischemia-Reperfusion Injury: Possible Involvement of Mitochondrial Component Separation. Oxidative Med. Cell. Longev., 1006636.10.1155/2021/1006636 ↗
38. Biomimicking Platelet-Monocyte Interactions as a Novel Targeting Strategy for Heart Healing10.1002/adhm.201600724 ↗
39. Ischemic postconditioning attenuates the inflammatory response in ischemia/reperfusion myocardium by upregulating miR499 and inhibiting TLR2 activation10.3892/mmr.2020.11104 ↗
40. Metallothioneins 1 and 2 Modulate Inflammation and Support Remodeling in Ischemic Cardiomyopathy in Mice10.1155/2016/7174127 ↗
41. Rawat, D.K., Hecker, P., Watanabe, M., Chettimada, S., Levy, R.J., Okada, T., Edwards, J.G., and Gupte, S.A. (2012). Glucose-6-Phosphate Dehydrogenase and NADPH Redox Regulates Cardiac Myocyte L-Type Calcium Channel Activity and Myocardial Contractile Function. PLoS ONE, 7.10.1371/journal.pone.0045365 ↗
42. Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity10.1046/j.1471-4159.2003.01756.x ↗
43. Solanine induces mitochondria-mediated apoptosis in human pancreatic cancer cells10.1155/2014/805926 ↗
44. Targeted delivery of fat extract by platelet membrane-cloaked nanocarriers for the treatment of ischemic stroke10.1186/s12951-022-01461-2 ↗
45. Platelet membrane coating coupled with solar irradiation endows a photodynamic nanosystem with both improved antitumor efficacy and undetectable skin damage10.1016/j.biomaterials.2017.12.028 ↗
46. Basics and recent advances in peptide and protein drug delivery10.4155/tde.13.104 ↗
47. Mitochondria-Targeted Antioxidant Peptide SS31 Prevents Hypoxia/Reoxygenation-Induced Apoptosis by Down-Regulating p66Shc in Renal Tubular Epithelial Cells10.1159/000354463 ↗
48. SS31 attenuates oxidative stress and neuronal apoptosis in early brain injury following subarachnoid hemorrhage possibly by the mitochondrial pathway10.1016/j.neulet.2019.134654 ↗
49. Grosser, J.A., Fehrman, R.L., Keefe, D., Redmon, M., and Nickells, R.W. (2021). The effects of a mitochondrial targeted peptide (elamipretide/SS31) on BAX recruitment and activation during apoptosis. BMC Res. Notes, 14.10.1186/s13104-021-05613-9 ↗
50. The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin10.1681/ASN.2012121216 ↗
51. The Bcl2 family: Regulators of the cellular life-or-death switch10.1038/nrc883 ↗
52. Bax induces cytochrome c release by multiple mechanisms in mitochondria from MCF7 cells10.1007/s10863-013-9508-x ↗
53. Mechanisms of caspase activation10.1016/j.ceb.2003.10.009 ↗
54. Bax, Bak and beyond—Mitochondrial performance in apoptosis10.1111/febs.14186 ↗
55. Apoptosis-Inducing Factor Triggered by Poly (ADP-Ribose) Polymerase and Bid Mediates Neuronal Cell Death after Oxygen-Glucose Deprivation and Focal Cerebral Ischemia10.1523/JNEUROSCI.2818-05.2005 ↗